Publications

Filters: policy
x
Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

EMA & Biosimilar Update: Trends from marketing authorisation applications, scientific advice procedures and policies – Peter Richardson, EBG Biosimilars 2015, London (PPT)

24 April 2015

Policy

Read More

The Science of Extrapolation – Martina Weise, EBG Biosimilars 2015, London (PPT)

23 April 2015

Policy

To view the full presentation, please click here. Part I […]

Read more

Considerations on WHO’s BQ Proposal – Joerg Windisch, 60th INN Consultation WHO, Geneva, 13 April 2015 (PPT)

13 April 2015

Policy

Read More

French Parliament Public Hearing on Biosimilar Medicines, Paris, 29 January 2015 – Intervention from EMA Spokesperson Camille Vleminckx

29 January 2015

Policy

Read More

Labelling & Naming – EBG Perspective, DIA Berlin 2014

3 December 2014

Policy

Read More

WHO BQ Proposal – EGA’s perspective, 59th INN Consultation, WHO, Geneva, 14 October 2014

14 October 2014

Policy

Read More

EMA mAb Workshop – Guideline on Similar Biological Medicinal Products

31 October 2013

Policy, Video

Read More

EMA mAb Workshop – Quality Target Product Profile in the Development of a Biosimilar

31 October 2013

Policy, Video

Read More

EMA mAb Workshop – Stepwise Approach to Non-Clinical Program

31 October 2013

Policy, Video

Read More

International Generic Pharmaceutical Alliance (IGPA) Letter Regarding TGA Guidance Titled “Evaluation of Biosimilars”, 2013

18 September 2013

Policy

Read More

Subscribe to our newsletter

[contact-form-7 id="1638" title="Newsletter subscription"]